Shikang Zhao

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Rheumatoid Arthritis

Top Venues

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Isaure Vanmeerbeek, Stefan Naulaerts, Jenny Sprooten, Raquel S Laureano, Jannes Govaerts, Rosa Trotta, Samantha Pretto, Shikang Zhao, Sarah Trusso Cafarello, Joren Verelst, Maarten Jacquemyn, Martyna Pociupany, Louis Boon, Susan M Schlenner, Sabine Tejpar, Dirk Daelemans, Massimilliano Mazzone, Abhishek Dinkarnath Garg
Targeting conserved TIM3 + VISTA + tumor-associated macrophages overcomes resistance to cancer immunotherapy. Science advances 10 (29) (2024)
Isaure Vanmeerbeek, Stefan Naulaerts, Jenny Sprooten, Raquel S Laureano, Jannes Govaerts, Rosa Trotta, Samantha Pretto, Shikang Zhao, Sarah Trusso Cafarello, Joren Verelst, Maarten Jacquemyn, Martyna Pociupany, Louis Boon, Susan M Schlenner, Sabine Tejpar, Dirk Daelemans, Massimilliano Mazzone, Abhishek Dinkarnath Garg
Targeting conserved TIM3 + VISTA + tumor-associated macrophages overcomes resistance to cancer immunotherapy. Science advances 10 (29) (2024)
Isaure Vanmeerbeek, Stefan Naulaerts, Jenny Sprooten, Raquel S Laureano, Jannes Govaerts, Rosa Trotta, Samantha Pretto, Shikang Zhao, Sarah Trusso Cafarello, Joren Verelst, Maarten Jacquemyn, Martyna Pociupany, Louis Boon, Susan M Schlenner, Sabine Tejpar, Dirk Daelemans, Massimilliano Mazzone, Abhishek Dinkarnath Garg
Targeting conserved TIM3 + VISTA + tumor-associated macrophages overcomes resistance to cancer immunotherapy. Science advances 10 (29) (2024)